$29.09 -0.18 (%) Bio-Reference Laboratories Inc - NASDAQ

Oct. 21, 2014 | 11:18 AM

Partner Headlines

  1. Small cap high short interest (Predictability = 5), Part 1

    GuruFocus | Oct. 16, 2014 | 12:20PM EST
  2. Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry With The Highest ROI

    Benzinga | Sep. 11, 2014 | 04:57AM EST
  3. Why I Like These Two Health Care Stocks

    GuruFocus | Aug. 29, 2014 | 10:08AM EST
  4. Earnings Scheduled For August 27, 2014

    Benzinga | Aug. 27, 2014 | 05:32AM EST
  5. LabCorp: A Leading Independent Diagnostic Laboratory

    GuruFocus | Aug. 22, 2014 | 17:47PM EST
  6. Myriad Genetics Guidance Disappoints, Q4 Edges Views

    IBD | Aug. 12, 2014 | 19:16PM EST
  7. Myriad Genetics' Earnings Face 'Angelina Jolie' Comps

    IBD | Aug. 11, 2014 | 12:43PM EST
  8. Morning Market Movers

    Benzinga | Jun. 5, 2014 | 09:40AM EST
  9. Earnings Scheduled For June 5, 2014

    Benzinga | Jun. 5, 2014 | 05:20AM EST
  10. 4 Attractive Small-Cap Growth + Value Stocks You Have Never Heard Of

    GuruFocus | Apr. 16, 2014 | 10:20AM EST
  11. Medical Diagnostic Labs Facing Medicare Headwinds

    GuruFocus | Mar. 25, 2014 | 19:35PM EST
  12. Myriad Stock Tumbles After Court Allows Rival To Sell

    IBD | Mar. 11, 2014 | 11:18AM EST
  13. Earnings Scheduled For March 4, 2014

    Benzinga | Mar. 4, 2014 | 04:35AM EST
  14. Historical Short Interest Of Stocks - New Feature Announcement

    GuruFocus | Jan. 17, 2014 | 11:18AM EST
  15. Myriad Price Cut Reflects Changing Gene-Test Industry

    IBD | Jan. 3, 2014 | 17:25PM EST
  16. Myriad Hit By Downgrades After Reimbursement Cut

    IBD | Dec. 30, 2013 | 11:09AM EST
  17. Earnings Scheduled For December 19, 2013

    Benzinga | Dec. 19, 2013 | 04:34AM EST
  18. Stocks With The Highest Short Interest - New Feature Announcement

    GuruFocus | Dec. 12, 2013 | 09:47AM EST
  19. UPDATE: Bank of America Lowers PT on Bio-Reference Laboratories Following Management Meetings

    Benzinga | Dec. 10, 2013 | 10:43AM EST
  20. Myriad Genetics Sued On Gene Patents; Stock Falls

    IBD | Dec. 2, 2013 | 11:16AM EST
  21. Alere Financial Says Bio-Reference Laboratories' Reimbursement Volatility has Created an Opportunity

    Benzinga | Nov. 29, 2013 | 10:58AM EST
  22. Bio-Reference cuts outlook

    IBD | Nov. 27, 2013 | 18:45PM EST
  23. Stocks Up Slightly In Late Trade; Pegasystems Climbs

    IBD | Nov. 27, 2013 | 14:52PM EST
  24. Bio-Reference Labs Slashes Guidance; Stock Plunges

    IBD | Nov. 27, 2013 | 11:24AM EST
  25. Morning Market Losers

    Benzinga | Nov. 27, 2013 | 09:55AM EST
  26. Earnings Scheduled For August 29, 2013

    Benzinga | Aug. 29, 2013 | 04:42AM EST
  27. BioReference Reports Purchase of Edge BioSystems' Service Business, No Terms Disclosed

    Benzinga | Aug. 21, 2013 | 08:33AM EST
  28. Myriad Genetics Falls On Downgrade, Despite Q4 Beat

    IBD | Aug. 14, 2013 | 15:17PM EST
  29. Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry With The Highest Revenue Estimates

    Benzinga | Feb. 5, 2013 | 20:08PM EST
  30. Bio-Reference Labs Offers Extremely Stable Earnings

    IBD | Jan. 25, 2013 | 11:54AM EST
  31. Quest Diagnostics Overhaul Continues With Unit Sale

    IBD | Jan. 16, 2013 | 05:11AM EST
  32. Quest Diagnostics Overhaul Continues With Unit Sale

    IBD | Jan. 16, 2013 | 05:11AM EST
  33. BioReference Laboratories Inc. Reports Operating Results (10-K)

    GuruFocus | Jan. 14, 2013 | 07:04AM EST
  34. Bio-Reference Labs, Inc. (BRLI) Sr. VP, Sec'y, Treasurer, CFO Sam Singer sells 2,000 Shares

    GuruFocus | Jan. 11, 2013 | 05:33AM EST
  35. Buffett-Munger Model Portfolio Posts Fourth Solid Year, Hits Refresh for 2013

    GuruFocus | Dec. 14, 2012 | 11:10AM EST
  36. Bio-Reference meets on Sandy

    IBD | Dec. 6, 2012 | 11:48AM EST
  37. Stocks Mixed As Rally Fades; Lululemon Bounces Back

    IBD | Dec. 6, 2012 | 06:39AM EST
  38. Bio-Reference Earnings Meet Views Despite Hurricane

    IBD | Dec. 6, 2012 | 03:07AM EST
  39. Earnings Scheduled For December 6, 2012

    Benzinga | Dec. 5, 2012 | 19:42PM EST
  40. Buffett-Munger Strategy: What Worked? What Didn't

    GuruFocus | Oct. 19, 2012 | 09:27AM EST
  41. Many Stocks Dip In Weak Trade Amid Market Correction

    IBD | Oct. 11, 2012 | 12:38PM EST
  42. Bio-Reference Laboratories Inc Reports Operating Results (10-Q)

    GuruFocus | Sep. 6, 2012 | 06:12AM EST
  43. Buffett-Munger Model Portfolio Gained 16.1% Year-to-Date

    GuruFocus | Sep. 5, 2012 | 11:12AM EST
  44. Stocks Back Off, So Does Volume

    IBD | Aug. 30, 2012 | 11:00AM EST
  45. Health Care Sector Wrap

    FoxBusiness | Aug. 30, 2012 | 10:44AM EST
  46. Stocks Trim Losses After Sliding Further

    IBD | Aug. 30, 2012 | 07:11AM EST
  47. Bio-Reference Shares Fall On Q3 Revenue Shortfall

    IBD | Aug. 30, 2012 | 07:08AM EST
  48. Stocks Trim Losses After Sliding Further

    IBD | Aug. 30, 2012 | 07:08AM EST
  49. First Solar, Sears Holdings Among Stocks Down on Above-average Volume Thursday

    FoxBusiness | Aug. 30, 2012 | 06:33AM EST
  50. US Stock Futures Down; Jobless Claims Data In Focus

    Benzinga | Aug. 30, 2012 | 00:36AM EST
Trading Center